Taipei Exchange - Delayed Quote TWD

Sinew Pharma Inc. (6634.TWO)

Compare
49.45
-0.20
(-0.40%)
At close: 2:36:11 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
328.00
6,229.00
462.00
Cost of Revenue
--
38.00
1,137.00
138.00
Gross Profit
--
290.00
5,092.00
324.00
Operating Expense
156,367.00
148,718.00
99,512.00
84,430.00
Operating Income
-156,367.00
-148,428.00
-94,420.00
-84,106.00
Net Non Operating Interest Income Expense
11,668.00
8,098.00
2,805.00
2,093.00
Pretax Income
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Net Income Common Stockholders
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Diluted NI Available to Com Stockholders
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Basic EPS
-2.07
-2.02
-1.54
-1.65
Diluted EPS
-2.07
-2.02
-1.54
-1.65
Basic Average Shares
69,858.35
69,298.00
59,498.00
51,293.00
Diluted Average Shares
69,858.35
69,298.00
59,498.00
51,293.00
Total Expenses
156,367.00
148,756.00
100,649.00
84,568.00
Net Income from Continuing & Discontinued Operation
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Normalized Income
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Interest Income
12,341.00
8,373.00
2,951.00
2,367.00
Interest Expense
673.00
275.00
146.00
274.00
Net Interest Income
11,668.00
8,098.00
2,805.00
2,093.00
EBIT
-144,006.00
-139,905.00
-91,429.00
-81,737.00
EBITDA
-118,903.00
-117,092.00
-68,785.00
-59,881.00
Reconciled Cost of Revenue
--
38.00
1,137.00
138.00
Reconciled Depreciation
25,103.00
22,813.00
22,644.00
21,856.00
Net Income from Continuing Operation Net Minority Interest
-144,679.00
-140,180.00
-91,575.00
-82,011.00
Normalized EBITDA
-118,903.00
-117,092.00
-68,785.00
-59,881.00
12/31/2020 - 6/30/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers